AGMB institutional ownership changes in Q2 2026: 7 institutions opened or added positions, 10 trimmed or exited. AGMB (AgomAb Therapeutics NV) is held by 13 institutional investors as of Q2 2026. Top institutional shareholders: Federated Hermes, Inc. ($21M), FMR LLC ($18.9M), Aberdeen Group plc ($11M). Institutions were selling, on balance.
Who's Trading
Latest move
Source dates: Price Nov 6, 2026 · Insiders Nov 6, 2026 · Activists May 15, 2026 · Congress none
Top Holders
Continue exploring
Questions investors ask about AGMB
Who owns AGMB?
13 institutional investors held AGMB on June 30, 2026, led by Federated Hermes, Inc. ($21M), FMR LLC ($18.9M) and Aberdeen Group plc ($11M).
How many hedge funds hold AGMB?
13 institutional investors reported AGMB in their 13F filings for the quarter ended June 30, 2026, $52.8M in all.
Are institutions buying or selling AGMB?
Selling, on balance. In Q2 2026, 10 institutions trimmed or exited AGMB and 7 institutions opened or added to positions.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer
